MLH1 and colorectal cancer: SSL-Ds with MLH1 hypermethylation are known to evolve into microsatellite instable-high (MSI-H) colorectal cancers (CRCs) with immune activation, while SSL-Ds without MLH1 alteration are associated with the development of microsatellite stable (MSS) CRCs with immune suppression.